New research suggests that fetal hemostasis is distinct and that impairment of angiogenesis rather than thrombocytopenia likely causes FNAIT-associated ICH. Additionally, results indicate that maternal IVIG therapy can effectively prevent this devastating disorder.

Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage